LGC

LGC Biosearch Technologies provides mission-critical analysis tools, reagents, and instruments for genomics workflows and molecular diagnostic development. The company offers end-to-end solutions, including oligonucleotide synthesis, qPCR probe design, and diagnostic kit development. Operating under cGMP standards, they maintain ISO 9001 and ISO 13485 certified manufacturing sites to support production scales ranging from nanomole quantities for research to gram-scale commercial supply. Their technical portfolio is supported by an R&D team specialized in fields such as synthetic organic chemistry, bioinformatics, and molecular biology, enabling the development of proprietary fluorophores, quenchers, and specialized genomic applications.

The company serves partners across global healthcare, agriculture, and life sciences, assisting in the development of tests for infectious diseases, oncology, and prenatal screening, as well as genotyping solutions for crop improvement. By providing scalable products and expert support from R&D through to large-scale commercialization, LGC Biosearch Technologies helps organizations bring new products to market efficiently and securely. Their focus on regulatory compliance, including GMP and GLP standards, ensures that customers receive high-quality, validated data and materials essential for clinical genomics assays and therapeutic development.